The efficacy of naloxone (NL), a broad spectrum opioid antagonist, on
retinal ischemia, was evaluated in a rat model of retinal ischemia wit
h histopathologic and morphometric criteria. Two intraperitoneal injec
tions of naloxone 3 mg/kg given immediately and 6 hr after reperfusion
showed beneficial effects to the retina as evaluated at 2, 7, and 14
days after reperfusion. Morphologically, the naloxone-treated group sh
owed better-preserved ganglion cells, nerve fiber layer, and inner nuc
lear layer. Morphometrically, in the treated groups, inner retinal thi
ckness at all three time points and ganglion cell counts at 7 days sho
wed higher values than vehicle controls. This beneficial effect of nal
oxone was dose-dependent with a minimal effective total dose of 6 mg/k
g. A possible role of opiate receptors in retinal ischemia is suggeste
d.